ICC

Clinical trials for ICC explained in plain language.

Never miss a new study

Get alerted when new ICC trials appear

Sign up with your email to follow new studies for ICC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo attack on tough liver cancer

Disease control Recruiting now

This study is testing a two-part treatment for advanced bile duct cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery. It combines chemotherapy delivered directly to the liver (HAIC) with immunotherapy drugs (Durvalumab or Pembrolizumab). The main goal is t…

Matched conditions: ICC

Phase: PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

ICC

Get alerted when new ICC trials appear

New combo attack on tough liver cancer